4/17
07:56 am
cmnd
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders [Yahoo! Finance]
Medium
Report
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders [Yahoo! Finance]
4/17
07:49 am
cmnd
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
Medium
Report
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
4/10
07:24 am
cmnd
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders [Yahoo! Finance]
Medium
Report
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders [Yahoo! Finance]
4/10
07:17 am
cmnd
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
Low
Report
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
4/9
08:25 am
cmnd
Clearmind Medicine CEO Issues Letter to Shareholders [Yahoo! Finance]
High
Report
Clearmind Medicine CEO Issues Letter to Shareholders [Yahoo! Finance]
4/9
08:07 am
cmnd
Clearmind Medicine CEO Issues Letter to Shareholders
High
Report
Clearmind Medicine CEO Issues Letter to Shareholders
3/27
09:12 am
cmnd
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
Low
Report
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
3/27
09:01 am
cmnd
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression [Yahoo! Finance]
Low
Report
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression [Yahoo! Finance]
3/19
07:55 am
cmnd
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
Medium
Report
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
3/13
08:14 am
cmnd
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
Low
Report
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
3/13
07:52 am
cmnd
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange [Yahoo! Finance]
Medium
Report
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange [Yahoo! Finance]
3/13
07:30 am
cmnd
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
High
Report
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
2/27
08:02 am
cmnd
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds [Yahoo! Finance]
Medium
Report
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds [Yahoo! Finance]
2/27
08:02 am
cmnd
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds [Yahoo! Finance]
Low
Report
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds [Yahoo! Finance]
2/27
07:58 am
cmnd
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
Low
Report
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
2/23
07:08 am
cmnd
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder [Yahoo! Finance]
High
Report
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder [Yahoo! Finance]
2/23
07:06 am
cmnd
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Medium
Report
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
2/5
08:05 am
cmnd
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China [Yahoo! Finance]
High
Report
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China [Yahoo! Finance]
2/5
07:51 am
cmnd
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
Low
Report
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
2/1
08:36 am
cmnd
Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center [Yahoo! Finance]
High
Report
Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center [Yahoo! Finance]
2/1
08:15 am
cmnd
Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
High
Report
Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
1/25
12:47 pm
cmnd
PCSA, ONCO and KAVL among mid-day movers [Seeking Alpha]
Medium
Report
PCSA, ONCO and KAVL among mid-day movers [Seeking Alpha]